Healthcare [ 5/13 ] | Medical Devices [ 82/159 ]
NYSE MKT | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 14, 23 | -0.07 Increased by +12.5% | -0.07 |
| Aug 10, 23 | -0.09 Decreased by -12.5% | -0.08 Decreased by -12.5% |
| May 11, 23 | -0.09 Decreased by -12.5% | -0.08 Decreased by -12.5% |
| Mar 2, 23 | -0.08 Decreased by -14.29% | -0.08 |
| Nov 10, 22 | -0.08 Decreased by -33.33% | -0.07 Decreased by -14.29% |
| Aug 8, 22 | -0.08 Decreased by -60% | -0.08 |
| May 4, 22 | -0.08 Decreased by -33.33% | -0.08 |
| Feb 28, 22 | -0.07 Increased by +22.22% | -0.07 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 1.09 M Decreased by -57.51% | -18.32 M Increased by +3.2% | Decreased by -1.68 K% Decreased by -127.82% |
| Jun 30, 23 | 1.08 M Increased by +8.75% | -20.66 M Decreased by -5.32% | Decreased by -1.91 K% Increased by +3.16% |
| Mar 31, 23 | 976 K Decreased by -8.44% | -22.22 M Decreased by -16.15% | Decreased by -2.28 K% Decreased by -26.87% |
| Dec 31, 22 | 2.46 M Decreased by -0.48% | -17.89 M Decreased by -12.65% | Decreased by -726.06% Decreased by -13.2% |
| Sep 30, 22 | 2.56 M Decreased by -0.31% | -18.92 M Decreased by -17.77% | Decreased by -738.35% Decreased by -18.13% |
| Jun 30, 22 | 994 K Decreased by -9.8% | -19.62 M Decreased by -48.94% | Decreased by -1.97 K% Decreased by -65.13% |
| Mar 31, 22 | 1.07 M Decreased by -48.82% | -19.13 M Decreased by -10.31% | Decreased by -1.79 K% Decreased by -115.55% |
| Dec 31, 21 | 2.48 M Increased by +123.47% | -15.88 M Decreased by -15.17% | Decreased by -641.4% Increased by +48.46% |
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.